(Q28377402)
Statements
Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors (English)
0 references
10 April 2000
0 references
16
0 references
6
0 references
517-28
0 references